Evidence mapPaperPMID 32379398Full record

ArticleObesity (Silver Spring, Md.)2020

Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study.

Jana Nano, Klodian Dhana, Eralda Asllanaj, Eric Sijbrands, M Arfan Ikram, Abbas Dehghan, Taulant Muka, Oscar H Franco

Open access · hybridAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. BMI trajectory and subsequent risk of type 2 diabetes among middle-aged women.Nutrition, metabolism, and cardiovascular diseases : NMCD · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 5 countries.

Jana Nano *Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-4731-5491
Klodian Dhana *Department of Internal Medicine, Division of Geriatrics and Palliative Medicine, Rush Medical College, Chicago, Illinois, USA.
Eralda AsllanajDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Eric SijbrandsDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
M Arfan IkramDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Abbas DehghanDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Taulant Muka *Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Oscar H Franco *Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLUniversity of Bern · CHRush University Medical Center · USUniversitätsmedizin Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePeople with diabetes show great variability in weight gain and duration of obesity at the time of diagnosis. BMI trajectories and other cardiometabolic risk factors prior to type 2 diabetes were investigated.

methodsA total of 6,223 participants from the Rotterdam Study cohort were included. BMI patterns before diagnosis of diabetes were identified through latent class trajectories.

resultsDuring a mean follow-up of 13.7 years, 565 participants developed type 2 diabetes. Three distinct trajectories of BMI were identified, including the "progressive overweight" group (n = 481, 85.1%), "progressive weight loss" group (n = 59, 10.4%), and "persistently high BMI" group (n = 25, 4.4%). The majority, the progressive overweight group, was characterized by a steady increase of BMI in the overweight range 10 years before diabetes diagnosis. The progressive weight loss group had fluctuations of glucose and marked beta cell function loss. The persistently high BMI group was characterized by a slight increase in insulin levels and sharp increase of insulin resistance accompanied by a rapid decrease of beta cell function.

conclusionsHeterogeneity of BMI changes prior to type 2 diabetes was found in a middle-aged and elderly white population. Prevention strategies should be tailored rather than focusing only on high-risk individuals.

Indexed as

Body Mass IndexAdultAgedCohort StudiesDiabetes Mellitus, Type 2FemaleHumansLatent Class AnalysisMaleMiddle AgedNetherlandsObesityOverweightRisk FactorsWeight GainWeight Loss

Identifiers

PMID32379398
PMCPMC7317538
OpenAlexW3022774088

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.